Camart N, André C, Trybou V, Bourdel M-C
Laboratoire de Psychologie Clinique des Faits Culturels, Université Paris-X, Nanterre.
Encephale. 2006 Nov-Dec;32(6 Pt 1):1011-8. doi: 10.1016/s0013-7006(06)76281-9.
This study analyses the short term effects of a cognitive-behavioral group therapy with 60 patients suffering from social phobia according to the diagnostic criteria of the DSM IV. The therapeutic program is based on 12 sessions of 2 hours (for 6 to 9 subjects) and includes exposure, cognitive restructuring and social skills training. The sample included 34 women and 26 men, with an average age of 34.8 years (SD=9.3). Most patients presented generalized social phobia (n=42; not generalized social phobia: n=18), and 24 received at least one comorbid axis I diagnosis. Subjects were evaluated before and after the therapy with instruments measuring the intensity of social phobia (Liebowitz Social Anxiety Scale), the assertiveness (Rathus Assertiveness Schedule), the disability associated with the disorder (Sheehan Disability Scale), anxiety and depression (Hospital Anxiety Depression Scale and Beck shortened Depression Inventory), and self-esteem (Rosenberg Self-Esteem Scale). The results show significant differences (p<0.001) between the pre and the post-test for all instruments. The effect sizes (ES) range from 1.29 (Liebowitz Scale, total score) to 0.51 (Sheehan item 3), exhibiting patients' improvement on all variables. The highest effect sizes are observed with the instruments specifically designed for the assessment of social phobia (Liebowitz, Rathus and Sheehan scales). Our patients show the major improvements in the Liebowitz Scale (ES=1.29), the best indicator for social phobia, concerning the intensity of anxiety in social situations (ES=1.28) and concerning the frequency of avoidance (ES=1.16). Logically, the effect sizes are somehow lower on Sheehan (ES=1.06) and Rathus (ES=1.00) scales, which are less specifically centered on the score symptoms of social phobia. The improvement is also significant but less remarkable in the other measurements. The Hospital Anxiety Depression Scale reveals a reduction in the level of anxiety and depression, however more significant for anxiety (ES=0.88) than for depression (ES=0.60), that is consistent with the fact that social phobia is an anxious disorder. The shortened Beck Depression Inventory confirms the level of depression decreases after therapy (ES=0.67) and we also observe a significant enhancement of self-esteem (ES=0.85). These findings confirm the short-term strong effectiveness of this therapeutic program. The present study shows that the therapeutic cognitive-behavior group techniques used are specifically effective both on the principal symptoms of social phobia as on other psychological aspects, which were not specifically the focus of this therapy, like general anxiety, depression, and self-esteem. However, this efficient study on 60 subjects needs to be extended to the evaluation of long term effects. It also needs to be reproduced to assess personality disorders that may make the treatment more difficult and are frequently comorbid with generalized social phobia.
本研究根据《精神疾病诊断与统计手册》第四版的诊断标准,分析了针对60名社交恐惧症患者的认知行为团体治疗的短期效果。治疗方案基于12节时长为2小时的课程(针对6至9名受试者),包括暴露疗法、认知重构和社交技能训练。样本包括34名女性和26名男性,平均年龄为34.8岁(标准差=9.3)。大多数患者表现为广泛性社交恐惧症(n=42;非广泛性社交恐惧症:n=18),24名患者至少有一项共病的轴I诊断。在治疗前后,使用测量社交恐惧症强度的工具(利博维茨社交焦虑量表)、自信(拉瑟斯自信量表)、与该障碍相关的残疾(希恩残疾量表)、焦虑和抑郁(医院焦虑抑郁量表和贝克抑郁量表简版)以及自尊(罗森伯格自尊量表)对受试者进行评估。结果显示,所有工具在测试前和测试后的差异均具有统计学意义(p<0.001)。效应大小(ES)范围从1.29(利博维茨量表总分)到0.51(希恩量表第3项),表明患者在所有变量上均有改善。在专门用于评估社交恐惧症的工具(利博维茨、拉瑟斯和希恩量表)上观察到最高的效应大小。我们的患者在利博维茨量表(ES=1.29)上有显著改善,该量表是社交恐惧症的最佳指标,在社交情境中的焦虑强度(ES=1.28)和回避频率(ES=1.16)方面也是如此。从逻辑上讲,希恩量表(ES=1.06)和拉瑟斯量表(ES=1.00)上的效应大小在某种程度上较低,因为它们较少专门针对社交恐惧症的症状评分。在其他测量中,改善也具有统计学意义,但不太显著。医院焦虑抑郁量表显示焦虑和抑郁水平有所降低,然而焦虑的降低更为显著(ES=0.88),抑郁的降低相对较小(ES=0.60),这与社交恐惧症是一种焦虑障碍的事实相符。贝克抑郁量表简版证实治疗后抑郁水平降低(ES=0.67),我们还观察到自尊有显著提高(ES=0.85)。这些发现证实了该治疗方案的短期强效性。本研究表明,所采用的治疗性认知行为团体技术在社交恐惧症的主要症状以及其他心理方面(如一般焦虑、抑郁和自尊,这些并非该治疗的特定重点)上均具有特效。然而,这项对60名受试者的有效研究需要扩展到对长期效果的评估。还需要进行重复研究,以评估可能使治疗更加困难且常与广泛性社交恐惧症共病的人格障碍。